{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-audit-report-handling-and-capa-integration”
},
“headline”: “SOP for Audit Report Handling and CAPA Integration”,
“description”: “This SOP outlines step-by-step procedures for handling audit reports and integrating Corrective and Preventive Actions (CAPA) in clinical trials, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Audit Report Handling and CAPA Integration

Purpose

The purpose of this SOP is to define procedures for handling audit reports and integrating Corrective and Preventive Actions (CAPA) in clinical trials. Proper documentation and CAPA management ensure that audit findings are addressed in a timely and effective manner, safeguarding subject safety, data integrity, and regulatory compliance.

Scope

This SOP applies to sponsors, CROs, QA auditors, investigators, and clinical operations staff responsible for audit report preparation, communication, CAPA planning, and closure. It covers sponsor audits, CRO/vendor audits, site audits, and system audits across multi-regional clinical trials.

Responsibilities

• Auditor: Prepares objective audit reports, classifies findings, and submits reports within defined timelines.
• QA Manager: Reviews audit reports, ensures accuracy, and approves distribution.
• PI/Site: Responds to findings with CAPA plans and evidence of implementation.
• Sponsor/CRO: Ensures audit reports are filed, CAPAs are tracked, and closure is documented.
• Clinical Operations Manager: Monitors CAPA follow-up and verifies completion.

Accountability

The sponsor retains accountability for ensuring audit reports are documented, CAPAs are implemented, and closure is verified. QA ensures independence of the process, while investigators and vendors are accountable for timely corrective actions.

Procedure

1. Audit Report Preparation
Auditor prepares draft audit report within 10 working days of audit completion.
Report includes audit scope, methodology, findings (critical/major/minor), and supporting evidence.
Use standardized Audit Report Template (Annexure-1).

2. Internal Review and Approval
QA Manager reviews draft report within 5 working days.
Sponsor approves final report within 15 working days.
Final report filed in TMF and shared with auditee.

3. Communication to Auditee
Provide final audit report to PI/vendor/CRO within 20 working days.
Include CAPA request form for each finding (Annexure-2).
Auditee acknowledges receipt within 5 working days.

4. CAPA Development
Auditee submits CAPA plan within 20 working days.
Plan must address root cause, corrective action, and preventive action.
Sponsor QA reviews CAPA plan for adequacy.

5. CAPA Implementation and Tracking
Site/vendor implements corrective actions (e.g., retraining, SOP updates, reconciliation).
CRA verifies CAPA implementation during follow-up visits.
Document in CAPA Log (Annexure-3).

6. Closure of Findings
QA verifies CAPA effectiveness and records closure in Audit Finding Closure Log (Annexure-4).
Critical findings require independent QA approval prior to closure.

7. Escalation
Unresolved or ineffective CAPA must be escalated to sponsor senior management.
Document escalation in Audit Escalation Log (Annexure-5).

8. Archiving
Archive all audit reports, CAPA forms, logs, and closure records in TMF.
Retain for minimum 15 years or as per regulatory requirements.

Abbreviations

• SOP: Standard Operating Procedure
• CAPA: Corrective and Preventive Action
• QA: Quality Assurance
• TMF: Trial Master File
• PI: Principal Investigator
• CRO: Contract Research Organization

Documents

1. Audit Report Template (Annexure-1)
2. CAPA Request Form (Annexure-2)
3. CAPA Log (Annexure-3)
4. Audit Finding Closure Log (Annexure-4)
5. Audit Escalation Log (Annexure-5)

References

• ICH E6(R2) – Good Clinical Practice
• FDA – Sponsor Audit Guidance
• EMA – Clinical Audit Guidelines
• CDSCO – Clinical Trial Audit Requirements
• WHO – Clinical Trial Audit Framework

Version: 1.0

Approval Section

Annexures

Annexure-1: Audit Report Template

Annexure-2: CAPA Request Form

Annexure-3: CAPA Log

Annexure-4: Audit Finding Closure Log

Annexure-5: Audit Escalation Log

Revision History

For more SOPs visit: Pharma SOP

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Sponsor-Audit-Planning-and-Execution”
},
“headline”: “SOP for Sponsor Audit Planning and Execution”,
“description”: “This SOP defines procedures for planning and executing sponsor audits in clinical trials, covering audit preparation, conduct, reporting, CAPA, and archiving to ensure compliance with FDA, EMA, CDSCO, WHO, and ICH GCP standards.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Sponsor Audit Planning and Execution

Purpose

The purpose of this SOP is to define the process for planning and executing sponsor audits in clinical trials. Sponsor audits ensure compliance with GCP, protocol requirements, and regulatory standards while verifying that clinical trial processes, vendors, CROs, and investigator sites operate in alignment with contractual and ethical obligations.

Scope

This SOP applies to sponsor QA, clinical operations, and external auditors engaged in sponsor-led audits of investigator sites, CROs, vendors, laboratories, and internal sponsor functions. It covers audit preparation, execution, reporting, CAPA management, escalation, and archiving across multi-regional trials governed by FDA, EMA, CDSCO, WHO, and ICH GCP requirements.

Responsibilities

• Sponsor QA: Plans, schedules, and executes audits.
• Clinical Operations: Provides logistical support and ensures corrective actions are implemented.
• Auditor: Conducts audit objectively, records evidence, and prepares audit reports.
• PI/Site Staff: Provides access to trial data, documents, and processes during audit.
• Vendor/CRO: Facilitates audits of outsourced activities and ensures CAPA compliance.
• Head of QA: Reviews audit reports and approves closure of findings.

Accountability

The sponsor is accountable for ensuring that audits are planned, executed, and documented. QA is accountable for the independence of audits, while Clinical Operations ensures CAPA implementation.

Procedure

1. Audit Planning
Develop Annual Audit Plan based on risk, trial phase, site activity, and regulatory priorities.
Document plan in Audit Planning Log (Annexure-1).
Include internal functions, investigator sites, CROs, and vendors.

2. Audit Preparation
Notify auditee at least 4 weeks in advance (except for for-cause audits).
Define audit scope, objectives, methodology, and checklist (Annexure-2).
Assign trained auditors with no conflict of interest.

3. Audit Execution
Conduct opening meeting with auditee.
Review TMF, ISF, informed consent, CRFs, source data, IP accountability, training records, and safety reporting.
Observe processes, interview staff, and verify compliance with SOPs and regulations.
Record evidence in Audit Notes (Annexure-3).

4. Audit Findings
Classify findings as Critical, Major, or Minor.
Discuss preliminary findings in exit meeting.
Document findings in Audit Findings Log (Annexure-4).

5. Audit Report
Prepare draft audit report within 10 working days.
Sponsor QA reviews and finalizes within 15 working days.
File final report in TMF and share with auditee.

6. CAPA Management
Auditee submits CAPA plan within 20 working days.
QA reviews and approves CAPA.
CRA verifies CAPA implementation during follow-up visits.
Document CAPA closure in CAPA Log (Annexure-5).

7. Escalation
Escalate unresolved critical findings to senior management.
Document in Escalation Log (Annexure-6).

8. Archiving
Archive audit plans, reports, findings, CAPAs, and escalation logs in TMF.
Retain documents for 15–25 years per regional regulations.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• CRA: Clinical Research Associate
• CRO: Contract Research Organization
• QA: Quality Assurance
• TMF: Trial Master File
• ISF: Investigator Site File
• CAPA: Corrective and Preventive Action

Documents

1. Audit Planning Log (Annexure-1)
2. Audit Checklist (Annexure-2)
3. Audit Notes (Annexure-3)
4. Audit Findings Log (Annexure-4)
5. CAPA Log (Annexure-5)
6. Escalation Log (Annexure-6)

References

• ICH E6(R2) – Good Clinical Practice
• FDA – Sponsor Audit Guidance
• EMA – Oversight of Clinical Trials
• CDSCO – Sponsor Audit Requirements
• WHO – Sponsor Audit Guidelines

Version: 1.0

Approval Section

Annexures

Annexure-1: Audit Planning Log

Annexure-2: Audit Checklist

Section	Item	Status
Informed Consent	Signed and dated forms
Drug Accountability	Complete reconciliation	Pending

Annexure-3: Audit Notes

Annexure-4: Audit Findings Log

Annexure-5: CAPA Log

Annexure-6: Escalation Log

Revision History

For more SOPs visit: Pharma SOP